BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17560095)

  • 1. Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems.
    Aumelas A; Serrero A; Durand A; Dellacherie E; Leonard M
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):74-80. PubMed ID: 17560095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable nanoparticles made from polylactide-grafted dextran copolymers.
    Nouvel C; Raynaud J; Marie E; Dellacherie E; Six JL; Durand A
    J Colloid Interface Sci; 2009 Feb; 330(2):337-43. PubMed ID: 19022457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of water-soluble and water-insoluble amphiphilic derivatives of dextran in organic medium.
    Covis R; Ladaviere C; Desbrieres J; Marie E; Durand A
    Carbohydr Polym; 2013 Jun; 95(1):360-5. PubMed ID: 23618280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of nanoparticles based on dextran-drug conjugates.
    Hornig S; Bunjes H; Heinze T
    J Colloid Interface Sci; 2009 Oct; 338(1):56-62. PubMed ID: 19635622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel polyester-polysaccharide nanoparticles.
    Lemarchand C; Couvreur P; Besnard M; Costantini D; Gref R
    Pharm Res; 2003 Aug; 20(8):1284-92. PubMed ID: 12948027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran Nanoparticle Synthesis and Properties.
    Wasiak I; Kulikowska A; Janczewska M; Michalak M; Cymerman IA; Nagalski A; Kallinger P; Szymanski WW; Ciach T
    PLoS One; 2016; 11(1):e0146237. PubMed ID: 26752182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic polysaccharides: useful tools for the preparation of nanoparticles with controlled surface characteristics.
    Durand A; Marie E; Rotureau E; Leonard M; Dellacherie E
    Langmuir; 2004 Aug; 20(16):6956-63. PubMed ID: 15274610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatically synthesized dextran nanoparticles and their use as carriers for nutraceuticals.
    Semyonov D; Ramon O; Shoham Y; Shimoni E
    Food Funct; 2014 Oct; 5(10):2463-74. PubMed ID: 25110170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): dextran-based surfactants.
    Wu M; Dellacherie E; Durand A; Marie E
    Colloids Surf B Biointerfaces; 2009 Feb; 69(1):141-6. PubMed ID: 19147334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
    Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
    Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfacial activity of modified dextran polysaccharide to produce enzyme-responsive oil-in-water nanoemulsions.
    Navascuez M; Gracia R; Marradi M; Díaz N; Rodríguez J; Loinaz I; López-Gállego F; Llop J; Dupin D
    Chem Commun (Camb); 2021 May; 57(37):4540-4543. PubMed ID: 33956004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface activity and emulsification properties of hydrophobically modified dextrans.
    Rouzes C; Durand A; Leonard M; Dellacherie E
    J Colloid Interface Sci; 2002 Sep; 253(1):217-23. PubMed ID: 16290850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized Dextran as a Macromolecular Crosslinker Stabilizes the Zein/Caseinate Nanocomplex for the Potential Oral Delivery of Curcumin.
    Rodriguez NJ; Hu Q; Luo Y
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31717559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First multi-reactive dextran-based inisurf for atom transfer radical polymerization in miniemulsion.
    Wu M; Forero Ramirez LM; Rodriguez Lozano A; Quémener D; Babin J; Durand A; Marie E; Six JL; Nouvel C
    Carbohydr Polym; 2015 Oct; 130():141-8. PubMed ID: 26076610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticulate delivery systems for alkyl gallates: Influence of the elaboration process on particle characteristics, drug encapsulation and in-vitro release.
    Chebil A; Léonard M; Six JL; Nouvel C; Durand A
    Colloids Surf B Biointerfaces; 2018 Feb; 162():351-361. PubMed ID: 29227921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of dextran as nanoscale drug carriers.
    Huang G; Huang H
    Nanomedicine (Lond); 2018 Dec; 13(24):3149-3158. PubMed ID: 30516091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.
    Porfire AS; Zabaleta V; Gamazo C; Leucuta SE; Irache JM
    Int J Pharm; 2010 May; 390(1):37-44. PubMed ID: 19712734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modification of poly(lactic acid) nanospheres using hydrophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique.
    Rouzes C; Gref R; Leonard M; De Sousa Delgado A; Dellacherie E
    J Biomed Mater Res; 2000 Jun; 50(4):557-65. PubMed ID: 10756314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physico-chemical characterization of polysaccharide-coated nanoparticles.
    Lemarchand C; Gref R; Lesieur S; Hommel H; Vacher B; Besheer A; Maeder K; Couvreur P
    J Control Release; 2005 Nov; 108(1):97-111. PubMed ID: 16169626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure design of multifunctional furoate and pyroglutamate esters of dextran by polymer-analogous reactions.
    Hornig S; Liebert T; Heinze T
    Macromol Biosci; 2007 Mar; 7(3):297-306. PubMed ID: 17366516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.